Clinical Trials Logo
  1. Home
  2. Moderate Acute Malnutrition
  3. NCT03474276

Comparing Several Strategies to Manage Moderate Acute Malnutrition Among Children From 6 to 24 Months Old — MALINEA  

Moderate Acute Malnutrition Clinical Trial

Official title:
A Multi-center, Randomized Controlled Comparison of Three Renutrition Strategies for the Management of Moderate Acute Malnutrition Among Children From 6 to 24 Months (Madagascar, Niger, Central African Republic and Senegal)

Clinical Trial Summary

The aim of this open-label randomized controlled trial conducted in four African countries (Madagascar, Niger, Central African Republic and Senegal) is to compare three strategies of renutrition for moderate acute malnutrition (MAM) in children based on modulation of the gut microbiota with enriched flours alone, enriched flours with prebiotics or enriched flours coupled with antibiotic treatment. Cognitive development of children (Senegal) will also be studied and compared.

Clinical Trial Description

The main objective of this study is to improve the nutrition strategy used to take in charge moderate acute malnutrition (MAM) which is the major milestone before severe malnutrition. This will be based on the modulation of the gut microbiota with adjunct product added to standard nutrition flours. The purpose of the MALINEA study is to compare three management strategies for Moderate Acute Malnutrition (MAM) in children aged between 6 months and 2 years old on recovery defined by a weight/size gain at 3 months. The 3 groups will be compared on several anthropometric measurements [Weight, length, Mid Upper Arm Circumference (MUAC)], clinical characteristics, adherence and tolerance to interventions between before and after a 3 months intervention Cognitive development of children (Senegal) will also be studied and compared, at inclusion, 3 months and 6 months after inclusion. The investigators will also investigate the microbiomes of malnourished children at inclusion and at 3 and 6 months after inclusion to compare it to the ones of normonourished children. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03474276
Study type Interventional
Source Institut Pasteur
Contact
Status Completed
Phase Phase 3
Start date January 31, 2018
Completion date June 30, 2019
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06056089 - Modified Dosage for Moderate Acute Malnutrition (MODAM-MAM) N/A
Not yet recruiting NCT06038071 - Family Mid-Upper Arm Circumference (MUAC) Follow-up After Recovery From Acute Malnutrition (MODAM-fMUAC) N/A
Completed NCT02571764 - Supplementary Food for Moderate Acute Malnutrition in Children N/A
Recruiting NCT06002438 - Eggs for Gut Health N/A
Completed NCT02272543 - Acceptability and Efficacy of 'Fish Surimi Peptide' in Under Five Children Suffering From Moderate Acute Malnutrition Phase 1
Not yet recruiting NCT06045104 - Alternative Feeding Regimen on Recovery of Children Aged 6-59 Months With Moderate Acute Malnutrition in Bangladesh. N/A
Recruiting NCT06214897 - Choline to Prevent SAM in Children With MAM N/A
Completed NCT03751475 - Optimizing Acute Malnutrition Management in Children Aged 6 to 59 Months in Democratic Republic of Congo N/A
Completed NCT01115647 - Treating Moderate Malnutrition in 6-24 Months Old Children N/A
Completed NCT01898871 - Effectiveness of Nutritional Products to Treat Moderate Acute Malnutrition Phase 2
Completed NCT01147198 - Ready to Use Supplementary Food in Moderate Childhood Malnutrition N/A
Not yet recruiting NCT06305442 - Microbiota Directed Food for Children With Moderate Acute Malnutrition N/A
Terminated NCT03087097 - Transfer of Healthy Gut Flora for Restoration of Intestinal Microbiota Via Enema for Patients in the Rehabilitative Phase of Malnutrition Phase 1
Completed NCT03146897 - Comparison of Four Different Supplementary Foods in the Treatment of Moderate Acute Malnutrition N/A